Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness by Stokes, BH, Dhingra, SK, Rubiano, K, Mok, S, Straimer, J, Gnädig, NF, Deni, I, Schindler, KA, Bath, JR, Ward, KE, Striepen, J, Yeo, T, Ross, LS, Legrand, E, Ariey, F, Cunningham, CH, Souleymane, IM, Gansané, A, Nzoumbou-Boko, R, Ndayikunda, C, Kabanywanyi, AM, Uwimana, A, Smith, SJ, Kolley, O, Ndounga, M, Warsame, M, Leang, R, Nosten, F, Anderson, TJ, Rosenthal, PJ, Ménard, D, Fidock, DA

Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model by Sá, JM, Kaslow, SR, Krause, MA, Melendez-Muniz, VA, Salzman, RE, Kite, WA, Zhang, M, Moraes Barros, RR, Mu, J, Han, PK, Mershon, JP, Figan, CE, Caleon, RL, Rahman, RS, Gibson, TJ, Amaratunga, C, Nishiguchi, EP, Breglio, KF, Engels, TM, Velmurugan, S, Ricklefs, S, Straimer, J, Gnädig, NF, Deng, B, Liu, A, Diouf, A, Miura, K, Tullo, GS, Eastman, RT, Chakravarty, S, James, ER, Udenze, K, Li, S, Sturdevant, DE, Gwadz, RW, Porcella, SF, Long, CA, Fidock, DA, Thomas, ML, Fay, MP, Sim, BKL, Hoffman, SL, Adams, JH, Fairhurst, RM, Su, X-Z, Wellems, TE

The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance by Murithi, JM, Pascal, C, Bath, J, Boulenc, X, Gnädig, NF, Pasaje, CFA, Rubiano, K, Yeo, T, Mok, S, Klieber, S, Desert, P, Jiménez-Díaz, MB, Marfurt, J, Rouillier, M, Cherkaoui-Rbati, MH, Gobeau, N, Wittlin, S, Uhlemann, A-C, Price, R, Wirjanata, G, Noviyanti, R, Tumwebaze, P, Cooper, RA, Rosenthal, PJ, Sanz, LM, Gamo, FJ, Joseph, J, Singh, S, Bashyam, S, Augereau, JM, Giraud, E, Bozec, T, Vermat, T, Tuffal, G, Guillon, J-M, Menegotto, J, Sallé, L, Louit, G, Cabanis, M-J, Nicolas, MF, Doubovetzky, M, Merino, R, Bessila, N, Angulo-Barturen, I, Baud, D, Bebrevska, L, Escudié, F, Niles, JC, Blasco, B, Campbell, S